Results 111 to 120 of about 13,966 (231)

Correction: Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies [PDF]

open access: gold, 2023
Sæmundur Rögnvaldsson   +34 more
openalex   +1 more source

Monoclonal Gammopathy of Clinical Significance (MGCS) and Related Disorders: A Review and the Role of Imaging

open access: yesDiagnostics
The term monoclonal gammopathy of clinical significance (MGCS) refers to a group of symptomatic monoclonal gammopathies that do not meet the diagnostic criteria for malignant plasma cell disorders, such as multiple myeloma or Waldenström ...
Ahmed O. El Sadaney   +3 more
doaj   +1 more source

Clinical clues for suspecting wild-type transthyretin cardiac amyloidosis in patients with monoclonal gammopathy of undetermined significance: a case report

open access: yesThe Egyptian Heart Journal
Background Myeloproliferative disorders, including monoclonal gammopathy of undetermined significance (MGUS), are often associated with amyloid light-chain (AL)-type cardiac amyloidosis (CA) but occasionally with wild-type transthyretin (ATTR) CA.
Tomoaki Haga   +8 more
doaj   +1 more source

Monoclonal gammopathy of undetermined significance: a contraindication for living kidney donation? [PDF]

open access: hybrid, 2011
Núria Serra   +4 more
openalex   +1 more source

Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study [PDF]

open access: bronze, 2009
Ola Landgren   +7 more
openalex   +1 more source

Platelet hyperactivation in multiple myeloma is also evident in patients with premalignant monoclonal gammopathy of undetermined significance [PDF]

open access: bronze, 2020
L. O’Sullivan   +5 more
openalex   +1 more source

Risk factors for monoclonal gammopathy of undetermined significance: a systematic review

open access: yesAnnals of Hematology, 2021
Maira A. Castañeda-Avila   +2 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy